Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline in Cushing syndrome
2006-005218-11Phase 3Active
- Sponsor
- Associazione Medici Endocrinologi
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cabergoline in Cushing's syndrome, sponsored by Associazione Medici Endocrinologi. Primary endpoint: Percentage of normalization of cortisol secretion. Started Apr 2007; status: active.
02
Drugs
cabergoline
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on 2006-005218-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005218-11.